Latent Autoimmune Diabetes in Adults (LADA) research hub

A follow-up project on the GADinLADA trial to test for the continued impact of HLA-DR3DQ2 on diabetes status and immune parameters 3 years after treatment with intranodal GAD-alum.

This follow-up study looks at adults with Latent Autoimmune Diabetes in Adults (LADA) who previously received an experimental treatment called Diamyd. Researchers want to see if the treatment is still helping their bodies make insulin three years later, particularly in people with a specific genetic background.